Conference Agenda

Patient Centricity & Collaboration - Day 2

Day 2: Tuesday 9th November 2021

  • Why diversity and inclusion in clinical trials are crucial?
  • Understanding critical barriers to minority and underserved patient communities participation in clinical trials
  • Actionable ways to improve diversity in clinical trials
  • What can the industry do to promote more diversity in the future?
  • Latest guidelines that make healthcare more inclusive
  • Major barriers to delivering patient-centred care
  • Focus on scaling and spreading proven interventions
  • Evidence to move forward and improve care for all patients, in all settings.
  • Major barriers to delivering patient-centred care
  • Focus on scaling and spreading proven interventions
  • Evidence to move forward and improve care for all patients, in all settings.
  • Current trends in digital health technology that can improve clinical trial recruitment and retention
  • Understanding patient needs to really make clinical trials accessible
  • How to maximise the value of technology
  • Digital innovation on the horizon

PANELLISTS:

Dr Oleksandr Gorbenko, Global Patient Centricity Director, Ipsen

 

Thierry Escudier, former Head of Clinical Development, Pierre Fabre

  • The importance of data democratization
  • Common challenges in clinical data review that hinders clinical trials
  • Strategies in overcoming these challenges
  • How to seamlessly integrate data from a variety of sources?
  • How to improve safety review efficiencies and reduce the timeline to critical studies? 

 

 

  • What it takes to get it right and how to avoid common pitfalls
  • Key priorities and opportunities for advocacy during COVID-19 and beyond
  • New ways of thinking to ensure the industry remains a credible and valuable partner now and in the future
  • Better collaboration between industry and patient organisations leads to improvements in patient care

Panellist: 

Victoria Hayes, Public Affairs Director, Kyowa Kirin

  • The patient community leading research
  • Real world data, as provided by patient advocacy and support orgs, determining and highlighting unmet
    needs
  • Patient-led registries and their contribution to the solutions
  • Examples of best practice already in existence

Robert Mitchell-Thain, Vice President, Liver Patients International

Senior Representative, NIHR Clinical Research Network

  • Two transformational case studies transforming how we think about the role of patients
  • Focussed on the why – a purposeful and structured approach to patient engagement
  • Models of co-production, pros and cons and why future healthcare providers will be led by patients

Professor Tony Bovaird, Chief Executive, Governance International

 

Shahid Sardar, Assoc. Director, Patient Engagement & Experience, The Princess Alexandra Hospital NHS Trust

  • COVID-19 pandemic has highlighted the need for patient-centricity, understanding the driversfor innovation in pharma
  • Partnering with patients and placing patient well-being at the core of all initiatives
  • Shifting towards disease-oriented to patient-centric
  • Innovative approaches for direct-to-patient assume significant importance for driving patient-centricity
  • Technologies that enhance the patient-centricity in pharma

Sponsors & Exhibitors

Scroll to Top